ICR Scientific Director: Dr. Morag Park

• Biography
• Message

Dr. Morag Park received her PhD in 1983 at Glasgow University, Scotland. For her postdoctoral studies she joined the lab of Dr. George Vande Woude at the National Institute of Cancer, US where she identified the Met receptor tyrosine kinase. She joined McGill University in 1988 where she is now a Professor in the Departments of Oncology, Biochemistry and Medicine. In addition, she holds the Diane and Sal Guerrera Chair in Cancer Genetics. Dr. Park is currently the Scientific Director of the CIHR Institute of Cancer Research. She has also served as Director of the McGill Molecular Oncology Group and joint head of the Cancer Axis at the McGill University Health Centre, and as a member of the Fonds de la Recherche en Santé du Québec, Réseau Cancer. She has a long standing interest in the molecular mechanisms of cancer. Dr. Park has published over 100 papers in peer-reviewed journals. She is recognized for her work on the Met receptor tyrosine kinase and signaling pathways that regulate cell migration and invasion in cancer. A major thrust of her work now focuses on human breast cancer and the importance of the tumour microenvironment to the outcome of this disease. Her work has been recognized with numerous awards including becoming a Fellow of the Royal Society of Canada.